Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead Plays Up Its Strength As Market Awaits Business Development Moves

Jan 10 2017

• By Joseph Haas

chess

Related Content

Combination Strategies A Common Thread In NASH R&D

Nov 21 2016

Gilead Coming To The End Of HCV Road With Triple-Drug Regimen

Nov 02 2016

Gilead's Late-Stage R&D Misfire Gives Respite To Competing Myelofibrosis Therapies

Nov 17 2016

When Will Gilead Make Its M&A Move?

Jul 26 2016

Related Companies

Gilead Sciences, Inc.

Novartis AG

ViiV Healthcare

Additional Topics

Business Strategies Launches M & A Commercial BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window